ABSTRACT
The tricuspid atresia associated with persistent truncus arteriosus is a rare anomaly. A case is presented of one male patient of three months age in which was detected a cardiac murmur. The diagnosis was made by echocardiography and confirmed by cardiac catheterization. The first step of the palliation was done with disconnection of the trunk of the pulmonary artery combined with a systemic- to- pulmonary shunt of 4 mm. The patient died 24 hours later for persistent metabolic acidosis.
Subject(s)
Humans , Infant , Male , Tricuspid Atresia , Truncus Arteriosus, Persistent , Cardiac Catheterization , Echocardiography , Fatal Outcome , Tricuspid Atresia , Truncus Arteriosus, PersistentABSTRACT
The tricuspid atresia associated with persistent truncus arteriosus is a rare anomaly. A case is presented of one male patient of three months age in which was detected a cardiac murmur. The diagnosis was made by echocardiography and confirmed by cardiac catheterization. The first step of the palliation was done with disconnection of the trunk of the pulmonary artery combined with a systemic- to- pulmonary shunt of 4 mm. The patient died 24 hours later for persistent metabolic acidosis.
Subject(s)
Tricuspid Atresia/surgery , Truncus Arteriosus, Persistent/surgery , Cardiac Catheterization , Echocardiography , Fatal Outcome , Humans , Infant , Male , Tricuspid Atresia/diagnosis , Truncus Arteriosus, Persistent/diagnosisABSTRACT
Ocho extractos crudos y dos fracciones de alcaloides obtenidos de siete especies vegetales provenientes de la flora colombiana, (abuta grandifolia, Piper holtonii, Acnistus arborescens, Croton leptostachys, Piper cumanense, Acacia farnesiana y Xilopia aromática) fueron evaluadas in vitro frente a tres especies de Leishmania danovanni y Leismania braziliensis y epimastigotes de Trypanosoma cruzi (tulahuen); dos de estas epecies (Acnistus arborescens y Piper cumanense) mostraron alta actividad en los ensayos realizados con valores de concentración inhibitoria 50 (CL50) menores de 12,5 ug/mL; cercanos a los obtenidos con el fármaco de referencia pentamidina 10 ug/mL.